Kauh JS - Search Results

1

Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group.

Ciombor KK, Feng Y, Benson AB 3rd, Su Y, Horton L, Short SP, Kauh JS, Staley C, Mulcahy M, Powell M, Amiri KI, Richmond A, Berlin J. Ciombor KK, et al. Among authors: kauh js. Invest New Drugs. 2014 Oct;32(5):1017-27. doi: 10.1007/s10637-014-0111-8. Epub 2014 Jun 4. Invest New Drugs. 2014. PMID: 24890858 Free PMC article. Clinical Trial.

2

Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203).

Meropol NJ, Feng Y, Grem JL, Mulcahy MF, Catalano PJ, Kauh JS, Hall MJ, Saltzman JN, George TJ Jr, Zangmeister J, Chiorean EG, Cheema PS, O'Dwyer PJ, Benson AB 3rd. Meropol NJ, et al. Among authors: kauh js. Cancer. 2018 Feb 15;124(4):688-697. doi: 10.1002/cncr.30967. Epub 2017 Dec 6. Cancer. 2018. PMID: 29211295 Free PMC article. Clinical Trial.

3

Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).

Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Dhanasekaran R, et al. Among authors: kauh js. J Surg Oncol. 2010 May 1;101(6):476-80. doi: 10.1002/jso.21522. J Surg Oncol. 2010. PMID: 20213741

4

Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study.

Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Dhanasekaran R, et al. Among authors: kauh js. HPB (Oxford). 2010 Apr;12(3):174-80. doi: 10.1111/j.1477-2574.2009.00138.x. HPB (Oxford). 2010. PMID: 20590884 Free PMC article.

5

Early clinical results from chemoradiation with 5-fluorouracil and oxaliplatin for locally advanced rectal cancer.

Lawson JD, Kauh J, Koshy M, Staley C, Landry J. Lawson JD, et al. Clin Colorectal Cancer. 2008 Sep;7(5):325-30. doi: 10.3816/CCC.2008.n.043. Clin Colorectal Cancer. 2008. PMID: 18794065

6

Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma.

Patel SH, Kneuertz PJ, Delgado M, Kooby DA, Staley CA 3rd, El-Rayes BF, Kauh JS, Sarmiento JM, Hanish S, Cohen C, Farris AB 3rd, Maithel SK. Patel SH, et al. Among authors: kauh js. Ann Surg Oncol. 2011 Nov;18(12):3384-90. doi: 10.1245/s10434-011-1775-3. Epub 2011 May 18. Ann Surg Oncol. 2011. PMID: 21590454

7

Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.

Kooby DA, Egnatashvili V, Srinivasan S, Chamsuddin A, Delman KA, Kauh J, Staley CA 3rd, Kim HS. Kooby DA, et al. J Vasc Interv Radiol. 2010 Feb;21(2):224-30. doi: 10.1016/j.jvir.2009.10.013. Epub 2009 Dec 21. J Vasc Interv Radiol. 2010. PMID: 20022765

8

LY3022855, an anti-colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial.

Dowlati A, Harvey RD, Carvajal RD, Hamid O, Klempner SJ, Kauh JSW, Peterson DA, Yu D, Chapman SC, Szpurka AM, Carlsen M, Quinlan T, Wesolowski R. Dowlati A, et al. Among authors: kauh jsw. Invest New Drugs. 2021 Aug;39(4):1057-1071. doi: 10.1007/s10637-021-01084-8. Epub 2021 Feb 23. Invest New Drugs. 2021. PMID: 33624233 Clinical Trial.

9

Differential expression of ERCC1 in pancreas adenocarcinoma: high tumor expression is associated with earlier recurrence and shortened survival after resection.

Maithel SK, Coban I, Kneuertz PJ, Kooby DA, El-Rayes BF, Kauh JS, Sarmiento J, Staley CA 3rd, Volkan Adsay N. Maithel SK, et al. Among authors: kauh js. Ann Surg Oncol. 2011 Sep;18(9):2699-705. doi: 10.1245/s10434-011-1610-x. Epub 2011 Mar 1. Ann Surg Oncol. 2011. PMID: 21360249

10

Single-fraction image-guided extracranial radiosurgery for recurrent and metastatic abdominal and pelvic cancers: short-term local control, metabolic response, and toxicity.

Perkins CL, El-Reyes B, Simon E, Kooby D, Torres W, Kauh JS, Staley CA, Landry JC. Perkins CL, et al. Among authors: kauh js. J Gastrointest Oncol. 2010 Sep;1(1):16-23. doi: 10.3978/j.issn.2078-6891.2010.010. J Gastrointest Oncol. 2010. PMID: 22811801 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters